7516-48-5 Usage
Uses
Used in Pharmaceutical Industry:
(+/-)-Dihydrolipoic acid is used as a therapeutic agent for its antioxidant properties, helping to neutralize harmful free radicals in the body and maintain the balance of other antioxidants such as vitamin C and E. This makes it a valuable compound in the development of treatments for various health conditions.
Used in Nutritional Supplements:
(+/-)-Dihydrolipoic acid is used as a dietary supplement to support energy metabolism and overall health. Its ability to improve insulin sensitivity and participate in the Krebs cycle makes it a popular choice for individuals looking to enhance their cellular energy production and manage type 2 diabetes.
Used in Environmental Remediation:
(+/)-Dihydrolipoic acid is used as a chelating agent for its ability to bind to certain metals, facilitating their removal from the body and the environment. This application is particularly relevant in industries where heavy metal contamination is a concern, such as mining and waste management.
Used in Research and Development:
(+/-)-Dihydrolipoic acid is used as a research compound in the study of energy metabolism, antioxidant mechanisms, and the potential treatment of various diseases. Its multifaceted properties make it an important tool in the development of new therapeutic strategies and understanding the underlying mechanisms of cellular processes.
Check Digit Verification of cas no
The CAS Registry Mumber 7516-48-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,5,1 and 6 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 7516-48:
(6*7)+(5*5)+(4*1)+(3*6)+(2*4)+(1*8)=105
105 % 10 = 5
So 7516-48-5 is a valid CAS Registry Number.
7516-48-5Relevant academic research and scientific papers
STEREOSELECTIVE REDUCTION OF RACEMIC N-HYDROXYAMINO ACIDS BY OPTICALLY ACTIVE THIOLS-IRON(II)
Nambu, Yoko,Endo, Takeshi
, p. 999 - 1002 (2007/10/02)
Kinetic resolution of racemic N-hydroxyamino acids by the reduction with optically active thiols and a catalytic amount of ferrous ion gave optically active amino acids presumably through enantiodifferentiating coordination of substrates to thiol-Fe(II) complexes.
